Evidence-based recommendations for the clinical use of recombinant human erythropoietin
- 31 August 1995
- journal article
- review article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 26 (2) , S1-S24
- https://doi.org/10.1016/0272-6386(95)90645-2
Abstract
No abstract availableKeywords
This publication has 112 references indexed in Scilit:
- Changes in left ventricular size, wall thickness, and function in anemic patients treated with recombinant human erythropoietinAmerican Heart Journal, 1992
- Vascular Access Thrombosis During Recombinant Human Erythropoietin TherapyAsaio Journal, 1992
- A Comparison of the Costs and Benefits of Recombinant Human Erythropoietin (Epoetin) in the Treatment of Chronic Renal Failure in 5 European CountriesPharmacoEconomics, 1992
- Factors limiting the erythropoietin response in rapidly growing infants with congenital nephrosis on a peritoneal dialysis regimen after nephrectomyThe Journal of Pediatrics, 1992
- Recombinant Human Erythropoietin for Patients with AIDS Treated with ZidovudineNew England Journal of Medicine, 1990
- Treatment of the Anemia of Progressive Renal Failure with Recombinant Human ErythropoietinNew England Journal of Medicine, 1989
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- A Comparison of Androgens for Anemia in Patients on HemodialysisNew England Journal of Medicine, 1981
- Hemodynamics of Uremic AnemiaCirculation, 1972
- Hemodynamics of Uremic AnemiaCirculation, 1971